Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of drospirenone + ethinyl estradiol tablets vs Yasmin in healthy Thai adult females under fasting
TCTR20220126002Phase 1Not yet recruiting
- Sponsor
- BioLab Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of drospirenone in contraception (2 arms), sponsored by BioLab Sciences. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on TCTR20220126002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220126002.